Suppressing neutrophil itaconate production attenuates Mycoplasma pneumoniae pneumonia
Cui Wang,Jun Wen,Zijun Yan,Yujun Zhou,Zhande Gong,Ying Luo,Zhenkui Li,Kang Zheng,Haijun Zhang,Nan Ding,Chuan Wang,Cuiming Zhu,Yimou Wu,Aihua Lei
DOI: https://doi.org/10.1371/journal.ppat.1012614
IF: 7.464
2024-11-06
PLoS Pathogens
Abstract:Mycoplasma pneumoniae is a common cause of community-acquired pneumonia in which neutrophils play a critical role. Immune-responsive gene 1 (IRG1), responsible for itaconate production, has emerged as an important regulator of inflammation and infection, but its role during M . pneumoniae infection remains unknown. Here, we reveal that itaconate is an endogenous pro-inflammatory metabolite during M . pneumoniae infection. Irg1 knockout (KO) mice had lower levels of bacterial burden, lactate dehydrogenase (LDH), and pro-inflammatory cytokines compared with wild-type (WT) controls after M . pneumoniae infection. Neutrophils were the major cells producing itaconate during M . pneumoniae infection in mice. Neutrophil counts were positively correlated with itaconate concentrations in bronchoalveolar lavage fluid (BALF) of patients with severe M . pneumoniae pneumonia. Adoptive transfer of Irg1 KO neutrophils, or administration of β-glucan (an inhibitor of Irg1 expression), significantly attenuated M . pneumoniae pneumonia in mice. Mechanistically, itaconate impaired neutrophil bacterial killing and suppressed neutrophil apoptosis via inhibiting mitochondrial ROS. Moreover, M . pneumoniae induced Irg1 expression by activating NF-κB and STAT1 pathways involving TLR2. Our data thus identify Irg1 /itaconate pathway as a potential therapeutic target for the treatment of M . pneumoniae pneumonia. M . pneumoniae is a common human pathogen that causes community-acquired pneumonia. Neutrophil infiltration has been widely recognized as a characteristic of M . pneumoniae pneumonia; however, the interaction between neutrophils and M . pneumoniae is not completely understood. Here we demonstrate a critical role of the Irg1 /itaconate metabolic pathway in neutrophils in the pathogenesis of M . pneumoniae pneumonia. We observe a positive correlation between neutrophil counts and itaconate levels in BALF from patients with severe M . pneumoniae pneumonia. We find that M . pneumoniae infection induces itaconate production in neutrophils, which dampens neutrophil bactericidal activity and impedes neutrophil apoptosis through inhibiting mitochondrial ROS (mtROS). Suppressing neutrophil itaconate production mitigates M . pneumoniae pneumonia in mice. We also find that M . pneumoniae induces Irg1 expression in neutrophils by activating NF-κB and STAT1 signaling pathways. Therefore, our findings suggest that targeting neutrophil itaconate production may be an effective therapeutic strategy for the treatment of M . pneumoniae pneumonia in humans.
microbiology,virology,parasitology